SLC39A6 and hepatocellular carcinoma: Additionally, miR-192 targets TRIM25 to inhibit proliferation and migration in hepatitis B virus-related hepatocellular carcinoma [61], and targets SLC39A6 to reduce tumor metastasis in hepatocellular carcinoma cells [62].